Centenial Surgical Suture reports Q2 FY27 results and approves fund-raising evaluation

Centenial Surgical Suture Limited has announced its standalone un-audited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors also took on record the resignation of Anuradha Kashikar as Whole Time Director. Furthermore, the Board considered a proposal for raising funds and approved an independent assessment of fund-raising alternatives.

Financial Results and Board Meeting Outcomes

Centenial Surgical Suture Limited has disclosed its standalone un-audited financial results for the quarter and half-year ending September 30, 2026. The results include the Statement of Assets and Liabilities and Cash Flow Statement for the same period, accompanied by a Limited Review Report from the Statutory Auditors. These financial statements were reviewed by the Audit Committee and subsequently taken on record by the Board of Directors.

Director Resignation and Appreciation

The Board of Directors also accepted the resignation of Ms. Anuradha Kashikar (DIN: 00804831) from her position as Whole Time Director, effective October 5, 2026. The company expressed sincere appreciation for Ms. Kashikar’s invaluable services, dedication, and contributions during her tenure, acknowledging her integral role in the company’s journey.

Fund Raising Consideration

In a significant strategic move, the Board considered a proposal for raising funds through various permissible modes. After deliberation, the Board decided to undertake a comprehensive, independent assessment of the financial viability, commercial feasibility, associated risks, and regulatory implications of available fund-raising alternatives before making any decision. The engagement of an independent professional agency or financial advisory firm for this evaluation has been approved in principle. Any subsequent decision regarding the amount, mode, pricing, timing, or issuance of securities will be subject to applicable statutory, regulatory, and shareholder approvals.

Publication of Results

The company is arranging to publish these financial results in newspapers as per Regulation 47 of the SEBI (LODR) Regulations, 2015. The information is also available on the BSE website and the company’s website, www.centenialindia.com.

Meeting Details

The Board of Directors’ meeting commenced at 05:35 p.m. and concluded at 05:50 p.m. on November 12, 2026.

Source: BSE

Previous Article

Bandhan Bank to meet investors at upcoming forums

Next Article

Reliance Power authorises key personnel for stock exchange disclosures